Skip to main content

Raquel Vidal Estrada

Psychologist specializing in Clinical Psychology, attached to the Psychiatry Service. Adjunct professor at the Faculty of Medicine of the Universitat Autònoma of Barcelona. PhD in Clinical Psychology from the UAB. My healthcare work focuses on the psychological treatment of neurodevelopmental disorders, such as fetal alcohol syndrome (FAS), attention deficit hyperactivity disorder (ADHD) and other genetically based cognitive-behavioral disorders in the child-juvenile domain.

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital
Psychologist
Psychiatry
Children's Hospital and Woman's Hospital

Raquel Vidal Estrada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital
Psychologist
Psychiatry
Children's Hospital and Woman's Hospital

Psychologist specializing in Clinical Psychology, attached to the Psychiatry Service. Adjunct professor at the Faculty of Medicine of the Universitat Autònoma of Barcelona. PhD in Clinical Psychology from the UAB. My healthcare work focuses on the psychological treatment of neurodevelopmental disorders, such as fetal alcohol syndrome (FAS), attention deficit hyperactivity disorder (ADHD) and other genetically based cognitive-behavioral disorders in the child-juvenile domain.

I am a psychologist specialized in clinical psychology. I graduated with honors and received a special mention in the National End of Career Award. I did the PIR residency in clinical psychology at the Hospital Universitari Vall d’Hebron. I have a PhD in Clinical Psychology from the UAB with a Cum Laude qualification, obtaining the Extraordinary Phd Award. I have been adjunct professor at the Faculty of Psychology at the UAB and accredited tutor for clinical psychology residents at the hospital. I am currently adjunct professor at the Faculty of Medicine of the UAB.
My clinical work and research activity focuses on the area of neurodevelopmental disorders such as fetal alcohol spectrum disorders (FAS), attention deficit hyperactivity disorder (ADHD) and other genetically based cognitive-behavioral disorders. In this area, our unit is part of the XUEC (Clinical Expertise Units in Minority Cognitive Behavioral Diseases of CatSalut) and the ERN (European Reference Network for complex diseases). I am a researcher in the Psychiatry, Mental Health and Addictions Group of the Vall d'Hebron Research Institute, a CIBERSAM member (Centro de Investigación Biomédica en Red de Salud Mental) and have published in scientific journals with impact factor.

Projects

Psiquiatria, Salut Mental i Addiccions

IP: Miquel Casas Brugué
Collaborators: Natalia Calvo Piñero, Carlos Jacas Escarcellé, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez, Maria Soler Artigas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35200
Reference: 2017SGR1461
Duration: 01/01/2017 - 30/09/2021

Psiquiatria, Salut Mental i Addicions (GRC)

IP: Miquel Casas Brugué
Collaborators: Núria Gómez Barros, Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 27000
Reference: 2014 SGR 1357
Duration: 01/01/2014 - 31/12/2016

Identificación de biomarcadores para el Trastorno por Déficit de Atención con Hiperactividad (TDAH): Estudio del perfil de expresión de microRNA transcriptome) en linfocitos mediante secuenciación de última generación de alto rendimiento

IP: José Antonio Ramos Quiroga
Collaborators: Núria Gómez Barros, Raquel Vidal Estrada
Funding agency: Instituto de Salud Carlos III
Funding: 82885
Reference: PI12/01139
Duration: 01/01/2013 - 30/04/2017

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Edoardo Caronna

Edoardo Caronna

Postdoctoral researcher
Headache and Neurological Pain
Read more
Selen Ozkan

Selen Ozkan

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Pediatric Neurology
Read more
Tamara Garcia Antolinez

Tamara Garcia Antolinez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.